title: Evaluation of iron oxide nanoparticle biocompatibility.
abstract: Nanotechnology is an exciting field of investigation for the development of new treatments for many human diseases. However, it is necessary to assess the biocompatibility of nanoparticles in vitro and in vivo before considering clinical applications. Our characterization of polyol-produced maghemite γ-Fe(2)O(3) nanoparticles showed high structural quality. The particles showed a homogeneous spherical size around 10 nm and could form aggregates depending on the dispersion conditions. Such nanoparticles were efficiently taken up in vitro by human endothelial cells, which represent the first biological barrier to nanoparticles in vivo. However, γ-Fe(2)O(3) can cause cell death within 24 hours of exposure, most likely through oxidative stress. Further in vivo exploration suggests that although γ-Fe(2)O(3) nanoparticles are rapidly cleared through the urine, they can lead to toxicity in the liver, kidneys and lungs, while the brain and heart remain unaffected. In conclusion, γ-Fe(2)O(3) could exhibit harmful properties and therefore surface coating, cellular targeting, and local exposure should be considered before developing clinical applications.
authors: Interface Traitement, Organisation et Dynamique des Systèmes, Université Paris 7, Paris, France.
authors: Amel
authors: A
authors: Hanini
authors: Alain
authors: A
authors: Schmitt
authors: Kamel
authors: K
authors: Kacem
authors: François
authors: F
authors: Chau
authors: Souad
authors: S
authors: Ammar
authors: Julie
authors: J
authors: Gavard
references: Nanomedicine (Lond). 2007 Dec;2(6):789-803
references: 18095846
references: Nanotechnology. 2009 Jun 3;20(22):225104
references: 19433870
references: Nat Biotechnol. 2003 Oct;21(10):1166-70
references: 14520401
references: Toxicol Sci. 2005 Dec;88(2):412-9
references: 16014736
references: Nano Lett. 2006 Aug;6(8):1794-807
references: 16895376
references: Toxicol Appl Pharmacol. 2009 Dec 15;241(3):260-8
references: 19747498
references: ACS Nano. 2009 Feb 24;3(2):307-16
references: 19236065
references: Nano Lett. 2005 Feb;5(2):331-8
references: 15794621
references: Proc Natl Acad Sci U S A. 1983 Jun;80(12):3734-7
references: 6407019
references: J Colloid Interface Sci. 2010 Jan 15;341(2):248-54
references: 19853857
references: Environ Health Perspect. 2007 Mar;115(3):403-9
references: 17431490
references: Toxicology. 2007 Jan 25;230(1):90-104
references: 17196727
references: Mol Pharm. 2010 Dec 6;7(6):1899-912
references: 20822168
references: Nature. 2006 Nov 16;444(7117):267-9
references: 17108940
references: Nat Nanotechnol. 2007 Aug;2(8):469-78
references: 18654343
references: Science. 2006 Feb 3;311(5761):622-7
references: 16456071
references: Curr Mol Med. 2006 Sep;6(6):651-63
references: 17022735
references: Toxicol In Vitro. 2005 Oct;19(7):975-83
references: 16125895